CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Vinci Pharmaceuticals Inc. cierra una financiación de Serie A para impulsar EPIPLANT™

EPIPLANT™Positive
AI Analysis

Summary

Vinci Pharmaceuticals Inc. closed a Series A funding round of over $8 million to advance its EPIPLANT™ drug delivery platform, bringing total capital raised to over $16.5 million when combined with initial funding.

Importance:5/10
Sentiment:
0.60
Series A FundingDrug Delivery PlatformCapital Raise

Read the original article

Published by PR Newswire Biotech on October 8, 2026 2:32 PM

Read Original